World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
48861
World Ranking
4354
National Ranking
2375

Overview

Barry E. Storer is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a stronger focus on subfields such as Hematology, Immunology, Genetics, Epidemiology, and Oncology. The main themes of their work revolve around Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, and Histone Deacetylase Inhibitors Research.

Barry E. Storer's publication record includes contributions to several leading scientific journals in hematology and transplantation sciences. Frequent venues where their work appears include:

  • Blood
  • Blood Advances
  • Biology of Blood and Marrow Transplantation
  • UNC Libraries
  • Haematologica

Recent notable papers by Barry E. Storer are:

  • Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia, 2021, Blood
  • Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades, 2020, Haematologica
  • An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML, 2022, Blood
  • Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation, 2020, Blood Advances
  • Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors, 2020, Blood

The scientist has worked extensively with coauthors who frequently collaborate on research projects, including:

  • Brenda M. Sandmaier
  • Paul J. Martin
  • Mohamed L. Sorror
  • David G. Maloney
  • Mary E.D. Flowers

Barry E. Storer's work integrates detailed investigations into hematopoietic stem cell transplantation methods and immune cell dynamics, reflecting an interdisciplinary approach to understanding blood cancers and transplantation-related immune responses. Their research outputs contribute data on different therapeutic intensities, conditioning regimens, genetic factors influencing transplantation outcomes, and graft-versus-host disease prophylaxis strategies.

Best Publications

  • Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

    Mohamed L. Sorror;Michael B. Maris;Michael B. Maris;Rainer Storb;Rainer Storb;Frederic Baron

  • Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

    Ted A. Gooley;Ted A. Gooley;Wendy Leisenring;Wendy Leisenring;John Crowley;John Crowley;Barry E. Storer;Barry E. Storer

  • Screening Sigmoidoscopy and Colorectal Cancer Mortality

    Polly A. Newcomb;Robert G. Norfleet;Barry E. Storer;Tanya S. Surawicz

  • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

    William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

    Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  • Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    Bianca D. Lemos;Barry E. Storer;Jayasri G. Iyer;Jerri Linn Phillips

  • Long-term survival among men with conservatively treated localized prostate cancer.

    Peter C. Albertsen;Dennis G. Fryback;Barry E. Storer;Thomas F. Kolon

  • Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Brenda M. Sandmaier;Barry E. Storer;Michael B. Maris

  • Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

    Mary E. D. Flowers;Pablo M. Parker;Laura J. Johnston;Alice V. B. Matos

  • Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.

    Jan Storek;Monja A. Dawson;Barry Storer;Terry Stevens-Ayers

  • Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

    David G. Maloney;Arthur J. Molina;Firoozeh Sahebi;Keith E. Stockerl-Goldstein

  • Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

    Paul J. Martin;George W. Counts;Frederick R. Appelbaum;Stephanie J. Lee

  • Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation

    Ming Tseh Lin;Barry Storer;Paul J. Martin;Paul J. Martin;Li Hui Tseng

  • Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.

    Mohamed L. Sorror;Michael B. Maris;Barry Storer;Brenda M. Sandmaier

  • Transplantation of Marrow Cells From Unrelated Donors for Treatment of High-Risk Acute Leukemia: The Effect of Leukemic Burden, Donor HLA- Matching, and Marrow Cell Dose

    Jorge Sierra;Barry Storer;John A. Hansen;Jean W. Bjerke

  • Major-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation

    Effie W. Petersdorf;John A. Hansen;Paul J. Martin;Ann Woolfrey

  • Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

    Mohamed L. Sorror;Sergio Giralt;Brenda M. Sandmaier;Brenda M. Sandmaier;Marcos J.G. de Lima

  • Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

    J.T. Slattery;R.A. Clift;C.D. Buckner;J. Radich

  • Hematopoietic cell transplantation (HCT)-specific-comorbidity index: A new tool for risk assessment before allogeneic HCT

    M.L. Sorror;M.B. Maris;M.B. Maris;R.F. Storb;R.F. Storb;F. Baron

Frequent Co-Authors

Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, exploring alternative online nursing degrees can be a practical first step. Many students look for flexible education options that accommodate busy schedules or those seeking career advancement.

For those aiming for advanced practice or leadership roles, choosing the cheapest dnp online program can provide a cost-effective path to a Doctor of Nursing Practice (DNP) degree. If you are a registered nurse, you might also consider the cheapest rn to bsn online programs to complete your Bachelor of Science in Nursing and open more career opportunities.

Non-nurses interested in entering the nursing profession quickly may pursue cheapest direct entry msn programs, which offer a streamlined path to a master’s degree. Additionally, students seeking the fastest route into nursing may benefit from adn programs (Associate Degree in Nursing), which may have fewer prerequisites and shorter completion times.

By comparing these online degrees and understanding their different career pathways, you can make informed choices that align with your personal and professional objectives in healthcare.

Best Scientists Citing Barry E. Storer

Trending Scientists